flexible precision.€¦ · to research and the world’s ﬁrst clinical trial (*2) of medical...

For research use only; not intended for diagnostic use.

One or more of these products are covered by patents, trademarks and/or copyrights owned or controlled by New England Biolabs, Inc.

For more information, please email us at [email protected].

The use of these products may require you to obtain additional third party intellectual property rights for certain applications.

ILLUMINA® is a registered trademark of Illumina, Inc.

© Copyright 2018, New England Biolabs, Inc.; all rights reserved.

be INSPIRED

drive DISCOVERY

stay GENUINE

FlexiblePrecision.NEBNext Direct® Custom Ready

Panels for NGS target enrichment

Employing the unique NEBNext Direct hybridization-

based enrichment method, NEBNext Direct Custom

Ready Panels allow rapid customization of targeted gene

panels for Illumina® sequencing. Select from a list of

genes for which baits have been carefully designed and

optimized to give complete coverage of the full coding

regions. High quality panels can be designed by you

and rapidly delivered, from any combination of genes.

NEBNext Direct Custom Ready Panels provide the

content you want with the performance you need.

• Choose from a single gene to hundreds of genes

• Experience unmatched specificity and

coverage uniformity

• Eliminate synthesis and optimization steps for

faster turnaround

• Improve sensitivity with our Unique Molecule

Index (UMI)

• Generate results in one day with our

automation-friendly workflow

For more information visit

NEBNextDirect.comKey target enrichment metrics demonstrate consistent performance across

a range of panel sizes. 100 ng of DNA was tested against panels of 1, 10,

25, 50 and 100 genes, and sequenced using Illumina® paired-end 150 bp

sequencing. Larger panels included all genes present in smaller panels.

NEBNext Direct Custom Ready Panelsdemonstrate optimum performance acrossa wide range of panel sizes

0

10

20

30

40

50

60

70

80

90

100

Percent(%

)

1 gene (3 kb)

10 gene (30 kb)

25 gene (70 kb)

50 gene (150 kb)

100 gene (280 kb)

> 25% of

Mean Coverage

% Selected% Aligned

For Research Use Only. Not for use in diagnostic procedures. © 2019 Thermo Fisher Scientific Inc. All rights reserved. All

trademarks are the property of Thermo Fisher Scientific and its subsidiaries unless otherwise specified. COL23095 0119

Find out more at thermofisher.com/attune

Let’s get to

the scienceAttune NxT Flow Cytometer

Flow cytometry

instrument

Evolutionary technology. Revolutionary potential.

Designed to help you realize the full potential of flow cytometry, the Invitrogen™

Attune™ NxT Flow Cytometer is modern technology for today’s science—and

tomorrow’s discoveries. Welcome to a new era in flow cytometry.

Home to more than 2,000 shrines and temples, Kyoto, Japan,conjures up the ancient past like few other places in the world. Yetjuxtaposed with this history is a city at the forefront of education andinnovation. Some of Japan’s most famous technology companies arebased in Kyoto. So too are some of its leading universities, beginningwith Kyoto University, the second-oldest national university in Japan.

Kyoto University is home to over 20,000 students—with about 10%coming from overseas—and to some of the country’s top researchers,including Tasuku Honjo, who last year became the sixth Kyoto Universityscientist to be awarded a Nobel Prize since 2000. Besides undertakingcutting-edge research, the university provides a world-class education.Anticipating that all its graduates will be exposed to data sciencein the workplace regardless of their field of study, one of its newesteducation efforts, the Center for Innovative Research and Education inData Science—founded in 2017 within the Institute for Liberal Arts andSciences—has designed a new curriculum that trains all students in thebasics of data science, including artificial intelligence and big data, nomatter their major.

Data science for all

Many of the memory-processor components in your smartphone wereprobably built in Japan. On the other hand,many of the applicationson that phone probably were not. Japan is renowned for its high-techmanufacturing, but, as a government advisory council of industry andacademic leaders concluded in May 2016, it is falling behind in datascience. By December of the same year, Kyoto University was one of sixuniversities selected by the Japanese government to change the waydata science is taught in Japan.

Data science is becoming omnipresent. No matter the industry—economics, journalism,medicine—data scientists are in demand. Today,a university is failing its students if it does not educate them in thisimportant field.

“Japan is very strong technologically, but not at the level of datamanagement. Our society needs more people who have competence indata science,” says Hiroshi Tamura, a professor at the center.

All students graduating from Japanese universities can expect theirmastery of a subject to match that of students from any university aroundthe world. However, compared with their peers overseas, Japanesestudents take considerably fewer courses outside of their specialty. So,while their proficiency in their chosen subject matches that of otherstudents, they may lack a certain breadth in their overall knowledge.

Akihiro Yamamoto, director of the center, says, “The Center forInnovative Research and Education in Data Science is trying to changethis by designing a wide range of courses that teach data science toall students, regardless of their major.” The center has university-widesupport, with each school being asked to nominate a data scientist to

teach the classes. The subject also appeals to the students—about half oflast year’s first-year students enrolled in its classes.

Preparing students for the futureThe Center for Innovative Research and Education in Data Science

provides a new vision for data science education. At universities aroundthe world, students are required to take courses in nonmajor subjectssuch as creative writing or computer programming, not because they willbecome professional writers or programmers, but because these skillsare expected for many jobs. Kyoto University sees data science similarly,and is committed to providing a new model for Japanese educationthat will enable its graduates to continue the university’s long history ofproducing leaders in their respective fields.

The unique learning environment offered by the university, togetherwith its world-class researchers, state-of-the-art facilities, and historicallegacy, offers a rare opportunity for students to walk in the footsteps ofsome of Japan’s greatest philosophers, thinkers, and scientists. Therethey can join the next generation of Japan’s brightest minds, changingthe world through data science. You are invited to join them too.

For more information: ds.k.kyoto-u.ac.jp/en

Democratizing data science in JapanThe Center for Innovative Research and Education in Data Science, Kyoto University

Members of

the Center for

Innovative Research

and Education in

Data Science.

Clockwise from top

right:

Hiroto Sekido,

Hiroshi Tamura,

Makoto P. Kato,

Kenshiro Ichimura,

Akihiro Yamamoto

(Director),

Naoto Nakano,

Satoko S. Kimura,

Masayuki Kimura

(ds.k.kyoto-u.ac.jp/

en/introduction/

member).

Advertorial

*Weller, MG, Analytical Chemistry Insights:11, 21-27 (2016).Antibodies shown: PD-L1 (A700-016) & Lamin A/C (A303-430A)©2019 Bethyl Laboratories, Inc. All rights reserved.

Brilliant visualizationSee the difference to make big breakthroughsin your tumormicroenvironment research

In the world of next generation immuno-oncology research, having confidence in your immunoassay results is vital.Unfortunately, 75% of antibodies in today’s market are non-specific or simply do not work at all.* That’s why atBethyl, we manufacture and validate every antibody on-site to ensure target specificity and sensitivity. More than10,000 independent citations over the past 15 years have proven that our antibodies will function as designed in

your assay Ñ and we offer a 100% guarantee. Work with Bethyl to bring your discovery into full focus.

See our data at bethyl.com/immuno-oncology

2018 Winner

Johannes Kohl, Ph.D.

For research on neural

mechanisms underlying

parental care

Eppendorf & Science Prize for Neurobiology

The annual Eppendorf & Science Prize for Neurobiology

is an annual international prize which honors young

scientists for their outstanding contributions to neuro-

biological research based on methods of molecular

and cell biology. The winner and finalists are selected

by a committee of independent scientists, chaired by

Science’s Senior Editor, Dr. Peter Stern. If you are 35

years of age or younger and doing great research, now

is the time to apply for this prize.

As the Grand Prize Winner, you could be next to receive

> Prize money of US$25,000

> Publication of your work in Science

> Full support to attend the Prize Ceremony held in

conjunction with the Annual Meeting of the Society

for Neuroscience in the USA

> 10-year AAAS membership and online subscription

to Science

> Complimentary products worth US$1,000

from Eppendorf

> An invitation to visit Eppendorf in Hamburg, Germany

It’s easy to apply! Write a 1,000-word essay and tell the

world about your work. Learn more at:

www.eppendorf.com/prize

Now It’s Your Turn!Application Deadline

June 15, 2019

AAAS®andScience®are

registeredtrademarksoftheAmericanSociety

fortheAdvancementofScience,USA.Eppendorf®andtheEppendorflogoare

registeredtrademarksofEppendorfAG,Germ

any.Allrights

reserved,

includinggraphicsandim

ages.Copyright©

2019byEppendorfAG.KurstinRoePhotography.

2018年获奖者

Johannes Kohl, Ph.D.

在亲代抚育神经机理方面

做出了杰出的贡献

Eppendorf & Science神经⽣物学奖

一年一度的 Eppendorf & Science神经生物学奖是一项

国际奖项，授予用分子与细胞生物学方法在神经生物学

领域取得非凡成果的青年科学家。冠军及入围候选人均

是由《Science》杂志高级编辑 Peter Stern博士领衔的

独立科学家所组成的委员会评出。年龄不超过 35岁的该

研究领域科学家可以申请参选。

您可能就是下⼀位获奖者并获得：

> 25,000美元奖金

>获奖论文发表在《Science》杂志上

>得以全额资助参与美国神经科学协会年会和颁奖仪式

> 10年 AAAS会员和《Science》电子期刊

>赠送价值 1,000美元的 Eppendorf产品

>获邀参观 Eppendorf位于德国汉堡的总部

申请非常容易，无需提名推荐程序！只需将您的研究成

果浓缩成 1,000字并上传即可。

要了解更多信息，请登陆：

www.eppendorf.com/prize

下一位获奖者就是你！申请截止日期

2019年 6月 15日





any.Allrights

reserved,


ages.Copyright©


Now It’s Your Turn!





any.Allrights

reserved,


ages.Copyright©


Full Stack

Genome

Engineering

Hundreds of human cell lines, including

cancer lines, in as few as four weeks

Edited pools are ready-to-assay or

can be selected for clonal expansion

Guaranteed 50% gene knockout or

your money back

Knockout Cell Pool

Synthego.com/ScienceMag

More than 200 conditions aretested in parallel to generatethe highest possible knockoutfrequencies.We guarantee atleast a 50% reduction inprotein levels, and commonlysee knockout efficiencies of

75% or greater.

ìOptimizedî Protocol

7%

Synthego Protocol

72%

Kn

oc

ko

ut

Sc

ore

(%)

0

100

80

60

40

20

160 180140 2000 20 40 60 80 100 120

Condition

200 Ways We

Optimize CRISPR

Visit Booth #4024 at AACR

ACCELERATING

REGENERATIVEMEDICINE

We’re applying our photographic film innovations

to help advance new treatments in the revolutionary

field of regenerative medicine. Over the last 80-plus

years, we’ve developed advanced technology

that controls complex chemical reactions in

photographic film that’s a mere 20 microns(*1) thick.

And today, that technology is being applied

to research and the world’s first clinical trial(*2)

of medical treatments that use high-quality

iPS cells. And in the future, we’ll strive to help

those suffering from a range of medical

conditions, such as those of the eyes, nerves,

heart and more. Of course, the challenges

are endless, but so are the possibilities.

Which is why we’ll never stop accelerating

regenerative medicine to help build a

stronger, healthier future for all.

*1 Thickness of layers excluding the base.

*2 Fujifilm’s iPS cells are being utilized in the world’s first clinical trial using iPS cells

conducted in the UK by the Australian company Cynata.

FUJIFILM and Fujifilm Value from Innovation are trademarks of FUJIFILM Corporation.

©2019 FUJIFILM Corporation. All rights reserved.

IMPROVING THE FUTURE

When you’re a company that has spent 85 years

striving to move the world forward, you never stop.

After achieving growth in global markets while

competing with industry rivals at the height of

photographic film’s relevance, never stop.

After turning the threat of the digital revolution

into opportunity despite the drastic decline in

photographic film demand, never stop.

And moving forward, we’ll never stop contributing

to society by developing products and services with

a wide range of advanced technologies.

Making smartphone displays react responsively

to human touch. Pushing the boundaries of

cinematography with 4K and 8K lenses.

Transforming commercial printing with leading-edge

inkjet technologies. Creating intelligent workplaces

with AI-powered solutions.

Advancing regenerative medicine to meet unmet

medical needs. And developing high-quality

3D imaging systems designed to enable

doctors to quickly diagnose conditions.

Because when it comes to creating value

from innovation, you can rest assured

we’ll never stop improving the future, so that

together, we can make the world a better place.

FUJIFILM and Fujifilm Value from Innovation are trademarks of FUJIFILM Corporation.

©2019 FUJIFILM Corporation. All rights reserved.

Exceptional Human Antibody Discovery Technology

Heavy Chain CDR3 Compositions of

a Human Individual and a Trianni Mouse

are Almost Identical

The Trianni Mouse® platform is a transgenic antibody

discovery platform ofering the entire human variable

gene diversity in a single organism.

The V(D)J gene segments in the Trianni Mouse are

chimeric, but the variable domains of antibodies made by

the mouse are entirely human. The result is human

antibody leads generated from antibody genes optimized

for function in the mouse.

To learn more about this innovative platform and how it can

help you leave your mark on therapeutic antibody discovery

and development, visit Trianni.com.

Trianni Mouse Antibodies are

a Match for Humans

The Best Antibody Discovery Technology

Is Now at Your Fingertips

TRIANNI

92 93 94 95 96 97 98 99 100 100A 100B100C 101 102 103

Amino Acid Position

HUMAN100

0

92 93 94 95 96 97 98 99 100 100A 100B100C 101 102 103

Amino Acid Position

AminoAcid

Frequency

Different amino acids are represented by different colors

100

0

AminoAcid

Frequency

For adetailedbrochure,please call (800) 252-4910

All prices are per person twin share + air

17050 Montebello RdCupertino, California 95014

Email: [email protected]

BETCHART EXPEDITIONS Inc.

Members and friends ofAAAS are invited to join

AAAS Travels on fascinatingtrips to all 7 contintents!

Discover the amazing antiquitiesand colossalmonuments ofEgypt. Visit the fabulous new

Alexandria Library andNationalMuseum, the great stone ramparts

of the Temple of Ramses II atAbu Simbel, and the ultimate

monuments of theOldKingdom,theGreat Pyramids and Sphinx!Explore the Valley of theKingsand cruise on theNile. Delight inthe exquisite Nubia and LuxorMuseums. $4,995 pp + air.

Discover EgyptNovember 1-15, 2019

Discover the rich heritage ofNewZealand. The dynamicgeologic forces can be seen inthe geyserfields of Rotorua, theplunging cliffs atMilford Sound,

the spectacular peaks andglaciers of the Southern Alps, andalong the rugged shore. Someof theworld’smost spectacularscenery is preserved in New

Zealand’s national parkswhichwewill visit. $4,995 pp + air.

NewZealand!Nov 17 – Dec 2, 2019

STAND TOGETHER

Be a Force for Science

GET THE FACTS

Understand the science behind the issues that matter.

FOLLOWAAAS ADVOCACY

Champion public discussion and evidence-based policy.

TAKE ACTION

Learn ways you can become an advocate and stand up for science.

F O R C E F O R S C I E N C E . O R G

ScienceWebinars help you keep pace with

emerging scientifc felds!

Stay informed about scientifc breakthroughs and discoveries.

Gain insights into current research from top scientists.

Take the opportunity to ask questions during live broadcasts.

Get alerts about upcoming free webinars.

Sign up at: webinar.sciencemag.org/stayinformed

new productsLIFE SCIENCE TECHNOLOGIES

1236 15 MARCH 2019 • VOL 363 ISSUE 6432 sciencemag.org/custom-publishing SCIENCE

Produced by the Science/AAAS Custom Publishing Office

Soft X-Ray XUV Spectrograph

Suitable for water-window imaging, high-

harmonic-generation laser spectroscopy, X-

ray plasma diagnostics, extreme ultraviolet

lithography (EUVL), optical characterization,

metrology, and calibration, the McPherson

%&'(��%��(�&�� &�(��&�-

promising performance over the wide

0.5 nmñ150 nm range, simply by indexing

'��&�� (��%��&��('�

for high-energy photons, including soft X-ray and extreme UV (XUV). It

does not scan with point detectors, but works exclusively with micro-

� ��(��(��(��(��'�&�'�(��'((��&��'((�&��

� (��(��&��&(��&��&��'(��(�'��'�� (��(��

�'(��&��'((�&��'��&&'��(��(�&��&�� (�'��&��

��(��&�� &�&�� (� ��'� (��&&�(��&��(�

(�(��(��!��(�"��(�� (��'��&��(#��(��

even orders of light is lower than either sawtooth or sinusoidal pro-

��(� �" �� (��$((�� (�(��(��(��'��&(�(��

interpretableóespecially at short wavelengths.

McPherson

For info: 800-255-1055

www.mcphersoninc.com

Newly offered instrumentation, apparatus, and laboratory materials of interest to researchers in all disciplines in academic, industrial, and governmental organizations are featured in this

space. Emphasis is given to purpose, chief characteristics, and availability of products and materials. Endorsement by Science or AAAS of any products or materials mentioned is not

implied. Additional information may be obtained from the manufacturer or supplier.

Electronically submit your new product description or product literature information! Go to www.sciencemag.org/about/new-products-section for more information.

Human iPSC-Derived Microglia

Axol Bioscience has introduced a new line of Human Induced Pluripotent

��.��.�� !��.��.-�+��,��,��.��-��,�� .��,�� -��.��

involvement in neurodegenerative diseases. Microglia are commonly

described as the immune cells of the brain. Axol generates physiologically

�.�.� ��"�� .��.-�+��,��,�� .�-, ,�� ,�-

mal karyotype, providing a homogenous population that is assay ready in

#��,��-��.�.��,��.$��,�,��.�.� �� , �-

ity with highly phagocytic activity and secretion of cytokines in response

�,��,. ��.��,�.$��.��.��,��.��.�� .�-

�� .��,�.� ��%��+&+��%!��, ��.�,�-��.��.�� .-

�.��,��.$��.��.-�, ��.�,�-��.��'&+�!� -��, ��.-�� -� �

-��,��,�.��.��()*�!��.�.$��.��, �,��.�.��. ,��.��. ��

��.��,��,��-.��.��,-.��,�� .�� .��,� ��-

tion in Alzheimerís disease, multiple sclerosis, and Parkinsonís disease.

Axol Bioscience

For info: 800-678-2965

www.axolbio.com

Sample Cooler

� 3�'�(3��&� ��3��11�3��1�� "� ��3��23��32�1��1��23�

�3��1��3�3��3��3��1�1��!)%*+��1�,�**+�#��1��3��-

�3��3�1��3�!-0&#��3�3�1��3��3�1��3��2��

2��1��3��3� ��3��3�32��3��3��3�

controlled air stream. Unlike some systems that use expensive, expend-

��3��1�3�� 2��1�3��1��1��2�1$�23�� 3�'�(3��&�

requires only house-compressed air to control temperature. Long,

nonmagnetic delivery lines allow positioning of the system remotely

from your sample areaóa particularly important consideration for

-0&��1��1��2��12��32�� 3�'�(3��&�3��3��

��2��1��2��3��3��1�1��1��1��1��2�2��

�33��3��3�! �.0#��1��/��3��3��3�!��#�� 3�'�(3��&��

�3��1�1��32��1��"��2��23��3�3��3��3��3��2��

��23�3�23��1�3�3��3��3��2��1��1��1��3��

data logging.

��

For info: 845-255-5000

��:��8�

ISH Automation Assays

,�8��:��:��:(��9:9��:� �8��8��:��8��8� ��

-9��:9��:��8��*.-��8�:�� 9��8��$+#'&��:��8�-

8�� :�:��:�*.-��8�:�0#�� :(�*::��1��9:�:�8�:9�

�8��:��+#�20)*3�45�*-� �8��:9�+'��+#'��9:��:��8��

*8��:��8��9:�� :8 �� 9:�:��8��8�� 8�*.-��:��:��8��

�8��:9��8��:��:��:(�:��:�� 8�8��-

��8�� 9�:��9�:�:�:(��:��8��8��:��:��:��9:��-

��:� ��"�8 ��":��:�*.-��8�:�0#�4��:��'*%��9�-%��

��:��:� ��*8��:6��*.-�4��:��8�� :��8��:�:9� ��

with additional protocols allowing dual staining with immunohistochem-

��8�� 8� 8�:��:��:��:� �9�:9�*.-��8�:��0#�*::��1��

,*27.��9��*)��8��:��+#�20)*3�45�*-��9:��:��:��:��

�9��8�:��:��:��,�8��:��:6��*.-��8�:��:��8� ��

��:�*.-��8�:� �:�9:�:��8��:�:��8��(:9��!��:��:99:9�

$//%)&�� :�� 8 ��:�*.-��::�:��8��:��:� ��:9��9��8��

ISH.

Bio-Techne

For info: 877-576-3636

www.acdbio.com

��

��:�-3)��8��:��-��#8� ��8��:(��:�9��:�:��:��-

�8�:�:��:� �:9��:��:��8��9��89:��:��:��-

tive index increment (dn�dc) is a critical parameter required to determine

absolute molecular weight using static light scattering (SLS) detectors.

-3)�8�:�� :�8 �� :�:��8��8��8�:��:��:��:��

of your SLS detector laser-operating wavelength, ensuring reliable and

�:��89 ��:��:� ��:�:��:��7�:�:��:�dn�dc value of the sample is

��:9��"�8 ��:�-3)�9��:�:��:��8�:�:��:� �:9��8��:��:�

�9��:��:��8��:��8��9:�:��8��:��8 ��8��:� �:9�

for determining concentrations can also be easily recollected and there-

fore utilized for further investigations.

Testa Analytical Solutions

%6��6-�$.!�/#�0&.��.#1&

��8��6��78 ��27�37�7�4��3�

Automated Endotoxin Detection

Lonza has created a next-generation automated endotoxin testing

��6��6�8��"(��8��8��8��8��6��8�6��8�5��

laboratory through process optimization and automation of routine man-

ual tasks associated with endotoxin testing. Automated endotoxin testing

can substantially reduce the potential for human error, enhancing the

�� 8��7��8��6��8� ��)��*6��+��,��'5�*�8�-

76�6 ��6��8��6�8��"(��8��8��7�8 ��8��8��

and dynamically ìscriptî the instructions to an automation template with

��8�6��6��8�8�7� �8��8�7�8��6��6��6��8 ��8��8�

7�� 8��8�6��8��8� ��8�8��8��8��8� ��8��6��6��-

��6��6�6�8��8��7�6�8�� 8�87��8 ��

the sample layout within the microplate.

Lonza

For info: 800-638-8174

��

futureAt GSK, we are poised to transform

drug discovery by taking a deeper look

into the genetic clues behind disease,

aided by large-scale genetic resources,

the latest technology and advanced

data science skills.

Our new approach to R&D has at its

core science related to cancer and to

the immune system, and will leverage

Human Genetics, Functional Genomics

and advanced analytics to improve the

probability of successfully developing

new medicines.

We are using human genetics to generate

new insights, and selecting targets that

have a high degree of validation based

on human genetics. To identify the next

generation of first-in-class targets, we

will leverage our exciting collaborations

with 23andMe, FinnGen, UK Biobank,

Open Targets and The Altius Institute,

amongst others. This shift to a genetics-

driven portfolio in a disease agnostic

manner will result in a portfolio of robust

lead candidate molecules with a higher

probability of success.

Join our team

We are currently building our capabilities

in Functional Genomics and Human

Genetics at GSK. As we continue to

grow both functions and invest in both

teams, we are hiring a range of scientists

including: Geneticists, Statistical

Geneticists, Computational Biologists,

Genomic Experts, Cell and Tissue Experts

and Gene Editing experts – all at a variety

of levels in newly created positions!

Immune system

T-cells attacking

a cancer cell

linkedin.com/company/glaxosmithkline

facebook.com/GSKcareers

@GSK _careersyoutube.com/GSKvision

Shape the

GSK has been helping millions of people

do more, feel better and live longer for

over 300 years.

Our goal is to be one of the world’s

most innovative companies, delivered

by people who are proud to say

they work in R&D at GSK. Can you

see yourself getting onboard at the

forefront of this technology revolution?

Are you passionate about helping patients,

have the courage to take smart-risks, and

have ambitions to develop and grow in a

company where you will be supported?

To apply and see all available positions

please go to gsk.com/careers and

search for ‘GSKGenetics’

Global bio-techne.com [email protected] TEL +1 612 379 2956 USA TEL 800 343 7475 Canada TEL 855 668 8722

Europe | Middle East | Africa TEL +44 (0)1235 529449 China TEL +86 (21) 52380373

For research use or manufacturing purposes only. Trademarks and registered trademarks are the property of their respective owners.

Expand Your CapabilitiesLeverage the expertise of our scientists

to outsource your project and obtain the custom solutions you need

Learn more | rndsystems.com/customservices

Setting the standard in quality reagents for over 30 years

Products and servicescustomized exactly to your needs

Save time and budget

Outsource the stressof troubleshooting and project management

Custom Solutions

flexible precision.€¦ · to research and the world’s ﬁrst clinical trial (*2) of medical...

Documents